HIIFS
TAK icon

Harel Insurance Investments & Financial Services’s Takeda Pharmaceutical TAK Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-110
Closed -$2K – 866
2020
Q4 		$2K Buy
+110
New +$1.93K ﹤0.01% 706
2019
Q4 		– Sell
-110
Closed -$2K – 555
2019
Q3 		$2K Hold
110
– – ﹤0.01% 480
2019
Q2 		$2K Hold
110
– – ﹤0.01% 456
2019
Q1 		$2K Buy
+110
New +$2.21K ﹤0.01% 435

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Harel Insurance Investments & Financial Services's TAK Position: Q1 2021 in Review

Harel Insurance Investments & Financial Services sold out of Takeda Pharmaceutical (TAK) in Q1 2021, closing a stake of 110 shares — an estimated $2K sold.

Harel Insurance Investments & Financial Services first reported a position in TAK in Q1 2019 and held it in 4 quarters. The position peaked at $2K in Q4 2020. 317 funds tracked by Wall St. Rank hold TAK as of Q1 2021.

  • Harel Insurance Investments & Financial Services reported no remaining Takeda Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 110 Takeda Pharmaceutical shares in Q1 2021, an estimated $2K.
  • Harel Insurance Investments & Financial Services first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 4 quarters.
  • Harel Insurance Investments & Financial Services's Takeda Pharmaceutical position peaked at $2K in Q4 2020.
  • 317 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2021.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2021, filed 27 Apr 2021.